Access Statistics for Aidan Hollis

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Contractual Approach to the Gray Market 0 0 3 417 0 1 6 2,053
Complementarity, Competition and Institutional Development: The Irish Loan Funds through Three Centuries 0 1 3 285 1 3 8 1,275
Exclusivity Restrictions in Markets with Adverse Selection: The Case of Extended Warranties 0 0 0 105 0 1 3 826
Generic drug pricing in Canada: components of the value-chain 0 0 0 96 0 1 4 282
Microcredit in Pre-Famine Ireland 1 1 4 328 1 2 8 1,702
New Approaches to Rewarding Pharmaceutical Innovation 0 0 1 90 0 1 7 146
Privacy, Driving Data and Automobile Insurance: An Economic Analysis 0 0 0 0 2 3 4 264
Privacy, Driving Data and Automobile Insurance: An Economic Analysis 0 0 0 62 1 3 12 209
Subsidizing the Competition 0 0 1 134 0 0 2 665
The Evolution of A Microcredit Institution: The Irish Loan Funds, 1720 - 1920 0 1 6 297 4 15 44 1,383
Total Working Papers 1 3 18 1,814 9 30 98 8,805


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A National Formulary for Canada 0 0 4 541 1 6 16 4,065
A contractual approach to the gray market 0 1 1 113 0 3 11 362
Co-authorship and the output of academic economists 0 0 1 54 0 5 7 197
Competition policy in open economies 0 0 1 32 0 0 1 160
Generic Drug Pricing and Procurement: A Policy for Alberta 0 0 1 3 0 0 1 10
Governance of electricity transmission systems 0 0 0 77 2 2 2 194
How do Brands’ “Own Generics” Affect Pharmaceutical Prices? 0 1 2 176 0 1 9 446
Industrial Concentration, Output, and Trade: An Empirical Exploration 0 0 0 31 0 0 0 84
Making Sure Orphan Drugs Don’t Get Left Behind 0 0 0 0 0 0 2 2
Microcredit in Prefamine Ireland 1 2 5 54 2 5 17 234
Microcredit: What can we learn from the past? 2 5 8 289 4 9 17 811
Microfinance and Famine: The Irish Loan Funds during the Great Famine 0 1 2 92 2 4 7 409
Newton's First Law as Applied to Pharmacies: Why Entry Order Matters for Generics 0 0 0 3 0 1 1 11
Preliminary Injunctions and Damage Rules in Patent Law 0 0 0 69 0 1 3 312
Price‐cap Regulation, Uncertainty and the Price Evolution of New Pharmaceuticals 0 0 1 8 0 0 1 26
Strategic Implications of Learning by Doing 0 0 0 84 1 4 6 546
Sustainable Financing of Innovative Therapies: A Review of Approaches 0 0 0 3 0 0 2 18
The Anti-Competitive Effects of Brand-Controlled "Pseudo- Generics" in the Canadian Pharmaceutical Market 0 0 3 221 0 1 12 680
The Role of Local Depositors in Controlling Expenses in Small-Scale Financial Intermediation: An Empirical Analysis 0 0 2 14 0 0 3 72
The importance of being first: evidence from Canadian generic pharmaceuticals 1 2 4 282 1 2 4 653
The large-scale integration of wind generation: Impacts on price, reliability and dispatchable conventional suppliers 0 1 3 47 0 2 5 131
The life-cycle of a microfinance institution: the Irish loan funds 0 3 7 140 3 8 18 402
The path of least resistance: Paying for antibiotics in non-human uses 0 0 0 3 0 0 1 19
Total Journal Articles 4 16 45 2,336 16 54 146 9,844


Statistics updated 2019-07-03